Research Peptides in the UAE

Why UAE Researchers Choose Remy Peptides

The UAE peptide market includes dozens of suppliers, but most lack the transparency that rigorous research demands. The difference between Remy Peptides and other UAE peptide suppliers comes down to three factors: published third-party COAs, prefilled pen formats that eliminate reconstitution variables, and temperature-controlled delivery designed for the UAE climate.

• Published COAs: Every batch ships with a Certificate of Analysis from Janoshik Analytical, an independent third-party laboratory. Current batch RETP002 is verified at 99.262% HPLC purity—not a generic “99%+” claim, but a specific, verifiable number. The full COA is published on our website before purchase.
• Prefilled pen format: Traditional lyophilised powder vials require manual reconstitution—introducing contamination risk and dosing variability. Our FlexiPen format delivers precise 0.1mg-per-click dosing with no preparation required.
• Cold-chain delivery: All peptide orders in the UAE ship in temperature-controlled packaging. Dubai deliveries arrive within 2 hours. This is critical during UAE summer months when ambient temperatures exceed 45°C and peptide stability is at risk.

What Peptides Are Available in Dubai?

Remy Peptides currently specialises in Retatrutide (LY3437943), the triple-agonist peptide from Eli Lilly that simultaneously activates GLP-1, GIP, and glucagon receptors. In Phase 2 clinical trials published in the New England Journal of Medicine, Retatrutide demonstrated 24.2% mean body weight reduction—the highest efficacy reported for any investigational obesity compound to date.

Volume pricing: AED 1,100/pen (3-pack) and AED 1,000/pen (5-pack) for the 30mg format. For bulk research procurement or institutional orders, contact us via Telegram at @propeptide.

Peptide Research in the UAE — Regulatory Context

Research peptides for in-vitro laboratory use are available in the UAE under specific conditions. All Remy Peptides products are labelled “For Research Use Only” in accordance with UAE Ministry of Health and Prevention (MoHAP) guidelines. These materials are not intended for human or veterinary administration.

The UAE has emerged as a growing hub for metabolic and obesity research, driven by one of the highest regional obesity prevalence rates (exceeding 30% of the adult population). Research institutions across Dubai, Abu Dhabi, and Sharjah are actively investigating next-generation GLP-1 receptor agonists, dual-agonist compounds, and triple-agonist peptides like Retatrutide. For a full overview of the UAE obesity research landscape, see our UAE obesity statistics and GLP-1 landscape analysis.

How to Evaluate a Peptide Supplier in the UAE

Not all peptide suppliers in Dubai and the UAE maintain the same quality standards. When evaluating a UAE peptide supplier, researchers should verify the following before ordering:

• Third-party COA: The Certificate of Analysis should come from an independent laboratory (not the supplier’s own in-house testing). Look for named labs like Janoshik Analytical with specific HPLC purity values, not rounded “99%+” claims.
• Published batch data: Reputable suppliers publish their COAs publicly, not just on request. If a supplier only provides a COA after payment, that’s a red flag.
• Product format: Prefilled pens reduce contamination risk compared to powder vials that require reconstitution. For UAE-based research, the elimination of manual preparation steps is especially valuable.
• Cold-chain logistics: In a country where summer temperatures regularly exceed 45°C, temperature-controlled delivery is not optional—it’s a baseline requirement for peptide integrity.
• Compliance labelling: All research peptides should be clearly labelled “For Research Use Only” with appropriate disclaimers.

Peptide Categories in UAE Research

UAE-based research laboratories work with several categories of peptides, each with different applications in metabolic, regenerative, and cellular biology research.

GLP-1 Receptor Agonists

GLP-1 (glucagon-like peptide-1) receptor agonists are the most widely studied class of metabolic peptides. Approved compounds include semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro). Retatrutide extends this class by adding GIP and glucagon receptor activity. Our GLP-1 medications in the UAE article covers availability and cost data for approved compounds.

Triple-Agonist Peptides

Retatrutide is the most advanced triple-agonist peptide in clinical development, simultaneously targeting GLP-1, GIP, and glucagon receptors. This three-receptor mechanism produced 24.2% weight reduction in Phase 2 data—exceeding the results of both single-agonist (semaglutide, ~15%) and dual-agonist (tirzepatide, ~22.5%) compounds. For a detailed mechanism breakdown, see our triple-agonist pathway analysis.

Regenerative & Tissue-Repair Peptides

BPC-157, GHK-Cu, and related peptides are studied for their roles in tissue repair, wound healing, and cellular regeneration. While Remy Peptides currently specialises in metabolic peptides (Retatrutide), the UAE research market includes significant activity in regenerative peptide studies.

Peptide Delivery Across the UAE

Remy Peptides provides temperature-controlled delivery for all research peptide orders across the United Arab Emirates.

• Dubai: 2-hour delivery — all areas including DIFC, Downtown, JBR, JLT, Business Bay, Dubai Marina, Dubai Hills, and Al Barsha
• Abu Dhabi: Next-day delivery
• Sharjah: Next-day delivery
• Ajman, RAK, UAQ, Fujairah: Next-day delivery

All shipments use insulated, temperature-controlled packaging to maintain cold-chain integrity from dispatch to laboratory receipt. For order tracking or research enquiries, contact us via WhatsApp at +34 672 737 521.

How Does Remy Compare to Other UAE Peptide Suppliers?